Skip to content

Fiberoptic Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Devices in Pediatric Patients

Evaluation of i-Gel and Air-Q sp3G Supraglottic Airway Device Placement by Fiberoptic Bronchoscopy and Comparison of Gastric Insufflation Volumes Using Ultrasound in Pediatric Patient

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07141498
Enrollment
91
Registered
2025-08-26
Start date
2025-08-28
Completion date
2026-01-09
Last updated
2026-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective Surgeries, Fiberoptic Bronchoscopy (FOB), Gastric Insufflation, Gastric Ultrasound, Laryngeal Mask Airways

Keywords

laryngeal mask, airway management, ultrasonography, child

Brief summary

This single-center, prospective, randomized controlled study aims to compare the placement accuracy of iGel and Air-Q sp3G supraglottic airway (SGA) devices in pediatric patients aged 1-8 years undergoing elective surgery under general anesthesia. Placement will be confirmed via fiberoptic bronchoscopy, and gastric insufflation will be assessed using ultrasound measurement of gastric antral cross-sectional area pre- and post-device placement. Secondary outcomes include postoperative complications such as sore throat, hoarseness and dysphagia.

Detailed description

This single-center, prospective, randomized controlled trial will be conducted in pediatric patients aged 1-8 years undergoing elective pediatric or urological surgery under general anesthesia. Participants will be randomized into two groups to receive either an iGel or an Air-Q sp3G device. Device placement will be confirmed intraoperatively via fiberoptic bronchoscopy using a standardized grading system and gastric antral cross-sectional area will be measured with ultrasound before device insertion, immediately after insertion and at the end of surgery to evaluate gastric insufflation. Secondary outcomes will include postoperative complications such as sore throat, hoarseness, dysphagia, mucosal bleeding, cough, laryngospasm, bronchospasm, nausea, vomiting and stridor. Intraoperative variables such as number of insertion attempts, ease of placement and peak airway pressure will also be recorded. The results are expected to identify which device offers better placement accuracy and lower gastric insufflation rates, thereby improving perioperative safety and postoperative recovery in pediatric patients.

Interventions

None listed

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 1-8 years * ASA I-III * Elective pediatric or urological surgery under general anesthesia with SGA use * Informed consent obtained from parents/guardians

Exclusion criteria

* Parental refusal or inability to consent * ASA \> III * Recent or current upper respiratory tract infection * History of difficult airway * Increased aspiration risk * Urgent/emergency surgery or non-fasted patients * Known allergy or contraindication to anesthetic agents * Severe asthma (attack within last 6 months) * Structural airway anomalies * Gastrointestinal pathology affecting stomach emptying * Previous stomach surgery

Design outcomes

Primary

MeasureTime frameDescription
Correct SGA Placement Rate via Fiberoptic BronchoscopyDevice placement will be assessed intraoperativelyIn pediatric patients undergoing elective surgery under general anesthesia, the correct placement of supraglottic airway devices (iGel vs. Air-Q sp3G) will be assessed using fiberoptic bronchoscopy grading (Grade 3-4 considered correct positioning).
Gastric insufflation volumegastric volume will be measured intraoperativelyGastric volume will be measured by ultrasound (USG) at three time points: Baseline (pre-induction): After IV induction, in supine position, before SGA insertion. Post-SGA insertion: Immediately after supraglottic airway (i-Gel or Air-Q sp3G) placement. End of surgery: Before emergence from anesthesia. The change in gastric volume across these time points will be compared between i-Gel and Air-Q sp3G groups.

Secondary

MeasureTime frameDescription
Peak Airway PressureIntraoperative - immediately after insertionPeak inspiratory airway pressure measured intraoperatively after SGA placement
Number of Attempts for Successful SGA PlacementIntraoperativeCount of insertion attempts required to achieve correct SGA positioning
Postoperative Sore Throat6 hours postoperativeIncidence of sore throat assessed by direct questioning at 6 hours after surgery.
Postoperative Hoarseness6 hours postoperativeIncidence of hoarseness assessed by direct questioning at 6 hours after surgery.
Postoperative Dysphagia6 hours postoperativeIncidence of swallowing difficulty assessed at 6 hours after surgery
Incidence of mucosal bleeding6 hours postoperativeIncidence of mucosal bleeding assessed by direct questioning at 6 hours after surgery.
Incidence of nausea6 hours postoperativeIncidence of nausea assessed by direct questioning at 6 hours after surgery

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 25, 2026